Capvizr
THE DEAL, AT A GLANCE

Elucid

From the announcement
01
Patient careSupport tools
Patient care tools
What it does] Elucid is a Boston-based medical technology company dedicated to bringing precision patient care, as currently practiced in oncology, to cardiology.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Who is involvedBacked by Elevage Medical Technologies | Elucid, both industry strategics, industry strategicsFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03What happenedElucid raised $55M Series D, announced 2026-09-02From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
04Why it mattersElucid's $55M Series D positions the company as a mid-market Healthcare & Life Sciences financing in an active funding tape, with the round ranking at the 48th…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Elucid · Financing Record

Explore source-linked visual explanations for Elucid. Unsupported claims are withheld while source review continues.

Record 11500 · Recorded date: 2026-09-02

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime